METHOD OF IDENTIFYING HETEROMULTIMERIC MODIFIED UBIQUITIN PROTEINS POSSESSING ABILITY TO BIND WITH LIGANDS Russian patent published in 2015 - IPC C07K14/00 C12N5/10 C12N7/00 C12N15/10 C12N15/62 C40B30/04 C40B40/06 C40B40/10 

Abstract RU 2553333 C2

FIELD: chemistry.

SUBSTANCE: invention relates to the field of biotechnology and can be used for the identification of heteromultimeric ubiquitins possessing an ability to bind with a ligand-antigen. The method includes the contact of a totality of heterodimeric modified ubiquitins, including two ubiquitin monomers, bound to each other by a head-to-tail scheme, with the potential ligand in a display way. Each of the said monomers is modified in a different way and contains 5-8 substitutions in positions 2, 4, 6, 8, 62, 63, 64, 65, 66 and 68 SEQ ID NO:1. After that, a heterodimeric modified protein, which has bound with the ligand with the binding affinity Kd in the range of 10-7-10-12 M and the monovalent binding activity. Claimed are DNA-libraries, responsible for obtaining a population of the said heteromultimeric ubiquitins, as well as libraries of proteins, obtained by the expression of the said DNA-libraries.

EFFECT: invention makes it possible to obtain the novel bonding proteins based on heteromultimeric ubiquitin, capable of specific high affinity binding with the selected ligands.

8 cl, 17 dwg, 4 ex

Similar patents RU2553333C2

Title Year Author Number
MODIFIED UBIQUITIN PROTEINS HAVING SPECIFIC BINDING ACTIVITY FOR EXTRADOMAIN B OF FIBRONECTIN 2010
  • Steuernagel Arnd
  • Fiedler Erik
  • Fiedler Markus
  • Kunert Anja
  • Nerkamp Joerg
  • Goettler Thomas
  • Haenssgen Ilka
RU2556820C2
ANTIBODIES TO POLYUBIQUITIN AND METHODS OF APPLICATION THEREOF 2011
  • Diksit Vishva
  • Kelli Robert F.
  • Matsumoto Marissa L.
RU2603093C2
TRAIL R2-SPECIFIC MULTIMERIC SCAFFOLDS 2011
  • Baka Manuel
  • Tisted Tomas
  • Svers Dzheffri
  • Tajs Devid
RU2628699C2
BISPECIFIC ASYMMETRIC HETERODIMERS COMPRISING ANTI-CD3 CONSTRUCTS 2013
  • Dixit Surjit Bhimarao
  • Spreter Von Kreudenstein Thomas
  • Ng Gordon Yiu Kon
  • Weisser Nina E.
RU2650868C2
MUTEINS OF HUMAN LIPOCALIN 2 (LCN2, HNGAL) WITH AFFINITY TO CERTAIN TARGET 2010
  • Skerra Arne
  • Gebauehr Mikhaehla
  • Khints Dominik
  • Raut Zabine
  • Machiner Gabriehle
  • Khjul'Smejer Martin
RU2564125C2
CD40L-SPECIFIC CARCASS STRUCTURES DERIVED FROM Tn3, AND METHODS FOR USE THEREOF 2012
  • Kojl Entoni
  • Baka Manuel
  • Tisted Tomas
  • Drabik Stejsi
  • Grinberg Lyuba
  • Novarra Shabazz
  • Oganesyan Vakhekh
  • Kherbst Ronald
  • Spenser Devid Kennet
RU2704992C2
HUMANISED ANTIBODIES TO AMYLOID BETA 2008
  • Andrea Pfajfer
  • Marija Pil'Gren
  • Andreas Mus
  • Rajan Uotts
RU2567151C2
APPLICATION OF ANTIBODY AGAINST AMYLOID-BETA IN CASE OF EYE DISEASES 2008
  • Marija Pil'Gren
  • Andrea Pfajfer
  • Andreas Mus
  • Rajan Uotts
RU2571859C2
COMPOSITIONS AND METHODS OF PULMONARY HYPERTENSION TREATMENT 2017
  • Kumar, Ravindra
  • Knopf, John
RU2748278C2
USING ANTI-AMYLOID BETA ANTIBODY IN OPHTHALMIC DISEASES 2008
  • Marija Pil'Gren
  • Andrea Pfajfer
  • Andreas Mus
  • Rajan Uotts
RU2542967C2

RU 2 553 333 C2

Authors

Kunert Anja

Nerkamp Joerg

Steuernagel Arnd

Dates

2015-06-10Published

2010-12-14Filed